ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck.

被引：1
|
作者：
Forster, Martin David
Mendes, Ruheena
Harrington, Kevin J.
Urbano, Teresa Guerrero
Baines, Helen
Spanswick, Victoria J.
Ensell, Leah
Hartley, John A.
Adeleke, Sola
Gougis, Paul
Leader, David
McDowell, Cathy
Lopes, Andre
Teague, Jonathan
Forsyth, Sharon
Beare, Sandy
机构：
[1] UCL, London, England
[2] Univ Coll London Hosp, London, England
[3] Inst Canc Res, London, England
[4] Royal Marsden Hosp, London, England
[5] Guys & St Thomas Hosp, London, England
[6] RTTQA Royal Marsden, London, England
[7] UCL, Inst Canc, London, England
[8] Canc Res UK, Combinat Alliance, London, England
[9] Canc Res UK, London, England
[10] UCL, Canc Trials Ctr, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.TPS6108
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS6108
引用
收藏
页数：3
相关论文
共 50 条
  • [1] ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced (LA) squamous cell carcinoma of the head and neck (HNSCC)
    Forster, M.
    Mendes, R.
    Urbano, T. Guerrero
    Evans, M.
    Lei, M.
    Spanswick, V.
    Miles, E.
    Simoes, R.
    Wheeler, G.
    Forsyth, S.
    White, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S789 - S790
  • [2] Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck
    Day, D.
    Prawira, A.
    Spreafico, A.
    Waldron, J.
    Karithanam, R.
    Giuliani, M.
    Weinreb, I
    Kim, J.
    Cho, J.
    Hope, A.
    Bayley, A.
    Ringash, J.
    Bratman, S., V
    Jang, R.
    O'Sullivan, B.
    Siu, L. L.
    Hansen, A. R.
    ORAL ONCOLOGY, 2020, 108
  • [3] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, J. G.
    Kim, D. H.
    Sohn, S. K.
    Baek, J. H.
    Chae, Y. S.
    Lee, K. B.
    Sohn, J. H.
    Park, J. S.
    Kim, J. C.
    Park, I. K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 300 - 300
  • [4] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    J G Kim
    S K Sohn
    D H Kim
    J H Baek
    S B Jeon
    Y S Chae
    K B Lee
    J S Park
    J H Sohn
    J C Kim
    I K Park
    British Journal of Cancer, 2005, 93 : 1117 - 1121
  • [5] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, JG
    Sohn, SK
    Kim, DH
    Baek, JH
    Jeon, SB
    Chae, YS
    Lee, KB
    Park, JS
    Sohn, JH
    Kim, JC
    Park, IK
    BRITISH JOURNAL OF CANCER, 2005, 93 (10) : 1117 - 1121
  • [6] Cisplatin-based concomitant chemoradiotherapy in locally advanced squamous cell carcinoma of head and neck: toxicity and feasibility analysis
    Atasoy, Beste Melek
    Dane, Faysal
    Sari, Murat
    Akgun, Zuleyha
    Yumuk, Perran Fulden
    Turhal, Nam Serdar
    Abacioalu, Ufuk
    Sengor, Meric
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2008, 23 (01): : 1 - 11
  • [7] EFFICACY OF CONCURRENT CHEMORADIOTHERAPY WITH CAPECITABINE AND CISPLATIN IN THE MANAGEMENT OF LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Gupta, S.
    Khan, H.
    Barik, S.
    Negi, M. P. S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S2 - S2
  • [8] Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    H Katori
    M Tsukuda
    I Mochimatu
    J Ishitoya
    S Kawai
    Y Mikami
    H Matsuda
    Y Tanigaki
    C Horiuchi
    Y Ikeda
    T Taguchi
    M Ono
    T Yoshida
    S Hirose
    Y Sakuma
    K Yamamoto
    British Journal of Cancer, 2004, 90 : 348 - 352
  • [9] Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Katori, H
    Tsukuda, M
    Mochimatu, I
    Ishitoya, J
    Kawai, S
    Mikami, Y
    Matsuda, H
    Tanigaki, Y
    Horiuchi, C
    Ikeda, Y
    Taguchi, T
    Ono, M
    Yoshida, T
    Hirose, S
    Sakuma, Y
    Yamamoto, K
    BRITISH JOURNAL OF CANCER, 2004, 90 (02) : 348 - 352
  • [10] Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Unsuitable to Receive Cisplatin-Based Therapy
    Porceddu, Sandro V.
    Scotte, Florian
    Aapro, Matti
    Salmio, Satu
    Castro, Ana
    Launay-Vacher, Vincent
    Licitra, Lisa
    FRONTIERS IN ONCOLOGY, 2020, 9
12345